Intravenous Nefopam Reduces Postherpetic Neuralgia during the Titration of Oral Medications |
Joo, Young Chan
(Department of Anesthesia and Pain Medicine, School of Medicine, Pusan National University)
Ko, Eun Sung (Department of Anesthesia and Pain Medicine, School of Medicine, Pusan National University) Cho, Jae Geun (Department of Anesthesia and Pain Medicine, School of Medicine, Pusan National University) Ok, Young Min (Department of Anesthesia and Pain Medicine, School of Medicine, Pusan National University) Jung, Gyu Yong (Department of Plastic Surgery, School of Medicine, Dongguk University) Kim, Kyung Hoon (Department of Anesthesia and Pain Medicine, School of Medicine, Pusan National University) |
1 | Turk DC, Okifuji A. Pain terms and taxonomies. In: Bonica's management of pain. 4th ed. Edited by Fishman SM, Ballantyne JC, Rathmell JP. Philadelphia (PA), Lippincott Williams & Wilkins. 2010, p 16. |
2 | Heel RC, Brogden RN, Pakes GE, Speight TM, Avery GS. Nefopam: a review of its pharmacological properties and therapeutic efficacy. Drugs 1980; 19: 249-67. DOI ScienceOn |
3 | Novelli A, Díaz-Trelles R, Groppetti A, Fernández-Sánchez MT. Nefopam inhibits calcium influx, cGMP formation, and NMDA receptor-dependent neurotoxicity following activation of voltage sensitive calcium channels. Amino Acids 2005;28: 183-91. DOI |
4 | Verleye M, André N, Heulard I, Gillardin JM. Nefopam blocks voltage-sensitive sodium channels and modulates glutamatergic transmission in rodents. Brain Res 2004; 1013:249-55. DOI ScienceOn |
5 | Biella GE, Groppetti A, Novelli A, Fernández-Sánchez MT, Manfredi B, Sotgiu ML. Neuronal sensitization and its behavioral correlates in a rat model of neuropathy are prevented by a cyclic analog of orphenadrine. J Neurotrauma 2003;20: 593-601. DOI ScienceOn |
6 | Czuczwar M, Czuczwar K, Cięszczyk J, Kiś J, Saran T, Łuszczki JJ, et al. Nefopam enhances the protective activity of antiepileptics against maximal electroshock-induced convulsions in mice. Pharmacol Rep 2011; 63: 690-6. DOI |
7 | Löscher W, Schmidt D. New Horizons in the development of antiepileptic drugs: Innovative strategies. Epilepsy Res 2006;69: 183-272. DOI ScienceOn |
8 | Marazziti D, Rotondo A, Ambrogi F, Cassano GB. Analgesia by nefopam: does it act through serotonin? Drugs Exp Clin Res 1991; 17: 259-61. |
9 | Evans MS, Lysakowski C, Tramèr MR. Nefopam for the prevention of postoperative pain: quantitative systematic review. Br J Anaesth 2008; 101: 610-7. DOI ScienceOn |
10 | Sunshine A, Laska E. Nefopam and morphine in man. Clin Pharmacol Ther 1975; 18: 530-4. DOI |
11 | Taniguchi Y, Ali SZ, Kimberger O, Zmoos S, Lauber R, Markstaller M, et al. The effects of nefopam on the gain and maximum intensity of shivering in healthy volunteers. Anesth Analg 2010; 111: 409-14. DOI ScienceOn |
12 | Alfonsi P, Passard A, Gaude-Joindreau V, Guignard B, Sessler DI, Chauvin M. Nefopam and alfentanil additively reduce the shivering threshold in humans whereas nefopam and clonidine do not. Anesthesiology 2009; 111: 102-9. DOI ScienceOn |
13 | Bouhassira D, Attal N, Fermanian J, Alchaar H, Gautron M, Masquelier E, et al. Development and validation of the Neuropathic Pain Symptom Inventory. Pain 2004; 108:248-57. DOI |
14 | Thakur R, Kent JL, Dworkin RH. Herpes zoster and postherpetic neuralgia. In: Bonica's management of pain. 4th ed. Edited by Fishman SM, Ballantyne JC, Rathmell JP. Philadelphia (PA), Lippincott Williams & Wilkins. 2010, pp 338-57. |
15 | Magrinelli F, Zanette G, Tamburin S. Neuropathic pain: diagnosis and treatment. Pract Neurol 2013; 13: 292-307. DOI |
16 | Novelli A, Groppetti A, Rossoni G, Manfredi B, Ferrero-Gutiérrez A, Pérez-Gómez A, et al. Nefopam is more potent than carbamazepine for neuroprotection against veratridine in vitro and has anticonvulsant properties against both electrical and chemical stimulation. Amino Acids 2007; 32: 323-32. DOI |
17 | Attal N. Neuropathic pain: mechanisms, therapeutic approach, and interpretation of clinical trials. Continuum (Minneap Minn) 2012; 18: 161-75. |
18 | Costigan M, Woolf CJ. Pain: molecular mechanisms. J Pain 2000; 1(3 Suppl): 35-44. |
19 | Durrieu G, Olivier P, Bagheri H, Montastruc JL; French Network of Pharmacovigilance Centers. Overview of adverse reactions to nefopam: an analysis of the French pharmacovigilance database. Fundam Clin Pharmacol 2007; 21:555-8. DOI ScienceOn |